People taking Wegovy and Ozempic have lower risk of suicidal thoughts vs. older drugs, study finds
The IndependentFor free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, events and updates from The Independent. Please try again later {{ /verifyErrors }} People taking the popular diabetes and obesity drugs Ozempic and Wegovy had a lower risk of suicidal thoughts than those taking other medications to treat the same conditions, a new federal study finds. NIH and Case Western Reserve University researchers analyzed electronic medical records from more than 1.8 million patients prescribed semaglutide or another drug to treat obesity or diabetes between 2017 and 2022. They found that people taking semaglutide had a 49% to 73% lower risk of first-time or recurring suicidal thoughts than those taking another drug for those conditions during a six-month follow-up period. The U.S. Food and Drug Administration also is investigating unconfirmed reports of suicidal thoughts or actions in people taking the GLP-1 drugs.